Functional gene polymorphism of matrix metalloproteinase-1 is associated with benign hyperplasia of myo- and endometrium in the Russian population.

Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int (2013) 0.87

Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma. Oxid Med Cell Longev (2015) 0.75

G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk. Bosn J Basic Med Sci (2016) 0.75

Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer. PLoS One (2017) 0.75

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol (2001) 3.00

The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev (2003) 2.30

Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci (2006) 1.96

Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev (2009) 1.90

The search for genes contributing to endometriosis risk. Hum Reprod Update (2008) 1.58

A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids. JAMA (2008) 1.45

Tissue injury and repair in the female human reproductive tract. Reproduction (2003) 1.33

My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol (2006) 1.22

Obstetric complications of fibroids. Obstet Gynecol Clin North Am (2006) 1.15

Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol (2008) 1.11

A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res (2002) 1.08

Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res (2001) 1.04

MMPs--role in cardiovascular development and disease. Front Biosci (2006) 1.03

The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China. Mol Hum Reprod (2005) 0.98

Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke (2001) 0.96

Leiomyomata uteri: hormonal and molecular determinants of growth. J Natl Med Assoc (2007) 0.90

Enhanced expressions of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding. Fertil Steril (2009) 0.88

Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB. PLoS One (2010) 0.88

NF-kappaB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter. Biochem Biophys Res Commun (2009) 0.88

Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels. Circ Cardiovasc Genet (2009) 0.85

Pathophysiology of fibroid disease: angiogenesis and regulation of smooth muscle proliferation. Best Pract Res Clin Obstet Gynaecol (2008) 0.84

Estrogen receptor-alpha gene (T/C) Pvu II polymorphism in endometriosis and uterine fibroids. Dis Markers (2009) 0.84

Sex steroidal modulation of collagen metabolism in uterine leiomyomas. Clin Exp Obstet Gynecol (2009) 0.83

Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur J Obstet Gynecol Reprod Biol (2003) 0.83

Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. J Soc Gynecol Investig (2004) 0.81

Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors. Cancer Invest (2011) 0.80

Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population. J Soc Gynecol Investig (2006) 0.77

Heavy menstrual bleeding: considering the most effective treatment option. Womens Health (Lond Engl) (2011) 0.77

Gonadotrophin hormone-releasing hormone analogue treatment of fibroids. Baillieres Clin Obstet Gynaecol (1998) 0.77

Expression of mRNA for chemokines and chemokine receptors in tissues of the myometrium and uterine leiomyoma. Bull Exp Biol Med (2008) 0.77

Common intronic D variant of ACE gene is associated with endothelial dysfunction in COPD. Respir Med (2013) 0.77

Planning trials with fibrosis-preventing agents. Int J Radiat Oncol Biol Phys (2005) 0.75

[Features of population composition of peripheral blood CXCR3-positive lymphocytes in chronic viral hepatitis c patients]. Zh Mikrobiol Epidemiol Immunobiol (2014) 0.75

[Quantitative determination of HBsAg in blood sera and hepatitis B virus covalently closed circular DNA in liver tissue as markers of chronic viral hepatitis B activity]. Zh Mikrobiol Epidemiol Immunobiol (2014) 0.75

Bacterial markers of periodontal diseases and their practical significance in dentistry. Bull Exp Biol Med (2007) 0.75